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INTRODUCTION 
 
 
 Chapter-I   Introduction 
 
1. INTRODUCTION1 
Medicinal or Pharmaceutical chemistry is a scientific discipline at the intersection of 
chemistry and pharmacology involved with designing, synthesizing and developing 
pharmaceutical drugs. Medicinal chemistry is concern with the organic, analytical and 
biological aspect of new drugs and involves the identification, synthesize and development 
of new chemical entities suitable for therapeutic use it also includes the study of existing 
drugs, their biological properties and their Quantitative structure activity relationship. 
Pharmaceutical chemistry is focused on quality aspects of medicine and aims to assure 
fitness for the purpose of medicinal products. 
 
In the glorious days of the 1950`s and 1960s chemists envisioned chemistry as the 
solution to a host of society`s needs. Indeed, they created many things which improve the 
quality of life on earth like dyes, plastics, cosmetics and other materials. At the same time 
chemistry brought about medicinal revolution that is, through antibiotics which conquered 
infectious disease. All these things prove Do Pont slogan “Better things for better living 
through chemistry”. 
 
Before the development of chemistry as a science, drugs that had been used were 
natural organic products or inorganic material, herbal and pharmacopeias listed plants that 
had been in use for thousands of years and resulted from efforts by various societies for the 
various illness and diseases encounter and recognize.    
 
The science now employs the most sophisticated development in technology and 
instrumentation including powerful molecular graphics with drug design software. 
Significant advances in x-ray crystallography and NMR has made the molecule to obtain 
detail representation of enzymes in other drug receptor. Thus the medicinal chemistry 
occupies a strategic position at the interface of biology and chemistry and it has enormous 
growth.  
 
Among the wide variety of heterocyclic that have been explored for developing 
pharmaceutically important molecules. 1, 3, 4 –oxadiazole derivatives have played vital role 
in the medicinal chemistry. There are large numbers of synthetic compounds with 
oxadiazole nucleus used for antibacterial, analgesic and anti inflammatory activity. The 
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broad spectrum of biological activity of 1,3,4 oxadiazole derivatives prompted us to 
synthesize the compounds and screen them for pharmacological activities. 
 
NUCLEUS INTRODUCTION (1,3,4-OXADIAZOLE) 
 
 
 
 
 
Molecular formula : C2H2N2O 
Molecular weight : 70.05g   
Appearance         : Liquid 
Boiling point  : 150-1520C 
 
 1,3,4 oxadiazoles  are the heterocycles that have received considerable attention 
during last two decades as the potential antibacterial, fungicidal, insecticidal, herbicidal, anti 
inflammatory, analgesic, antipyretic, anti tubercular, sedative, hypnotics, hypoglycemic 
agents, dyes and x-ray contrast materials . 
 
 Derivatives of 1,3,4-oxadiazole constitute an important family of heterocyclic 
compounds. There are several methods available in the literature for the synthesis of 1,3,4-
oxadiazole. However, some of these methods suffer from disadvantages such as long 
reaction times, lower yields; require severe condition by using strong or toxic oxidants. The 
oxadiazole chemistry has been developed extensively and is still developing. Presently, 
there are a number of drugs used clinically, which comprise oxadiazole moiety in 
association with various heterocyclic rings. In view of this a project was undertaken to 
synthesize a new series of 1,3,4-oxadiazoles containing the aldehyde. For these reasons the 
chemistry of 1,3,4-oxadiazoles has been the subject of many investigations. 
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SYNTHESIS OF 1,3,4 OXADIAZOLE43 
 
N
HO
HO
Indole-2-carboxylic acid
+ S
O
Cl
Cl
Thionyl chloride
+ OH
Refluxing 
for 8-10 hrs
Methanol
 
 
 
 
 
 
Refluxing 
for 4 hrs
N
H
CONH.NH2
Indole 2 CarboxyhydrazideIndole 2 carboxylate
N
H
COOCH3
Refluxing
for 4 hrs
with 
substituted 
benzaldehyde
 
 
 
 
 
Hydrazone
N
H
CONH N CH
R
Refluxing for 4 hrs
Chloramine T
 
 
 
 
 
 
N
H N N
O R
1,3,4-Oxadiazole derivative  
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RING SYNTHESIS 
 1,3,4-oxadizoles are available by cyclodehydration of N,N1-diacylhydrazines or their 
equivalents. They are also available from tetrazoles or by oxidative cyclisation of acyl 
hydrazones. 
 
ph
O
HN.NH2
HC(OEt)3,heat
71%
NN
Oph  
 
 1,3,4-oxadiazoles are formed on heating tetrazoles with acylating agents via  
rearrangement of a first formed 2-acyl derivatives. 
 
NN
Oph
(ph(CH2)3CO)2O Pyridine, 90oC
92%
NN
Oph (CH2)3ph  
 
LEAD MOEITY 
 As the oxadiazole and aldehyde with amino group possess diverse biological 
activity, the present work has been done on constructing the two moieties and synthesizes 
compounds which were screened for their anti inflammatory activity. 
 
R     -     Different Aldehydes 
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2. REVIEW OF LITERATURE 
¾ Praveen Kumar et al. (2010)12 synthesized 1-[(5 substituted-1,3,4-oxadiazol-2-yl) 
methyl]-4-propylpiperazines was carried out by refluxing the 1-propyl piperazine 
with ethylchloroacetate in dry acetone in presence of potassium carbonate and 
subsequent hydrazinolysis with hydrazine hydrate. Finally 2-(4-propylpiperazin-1-
yl)aceto hydrazide was treated with appropriate carboxylic acids in presence of 
phosphorous oxy chloride to produce title compounds. The newly synthesized 
compounds were tested for its anti bacterial, anti fungal and anthelmintic activity. 
 
¾ Ghodsi et al. (2009)13 synthesized 2-amino-1, 3, 4-oxadiazole compound via 
cyclization of 2-(2,4-dichlorothiazol-5-yl)methylene)hydrazine carboxamide in the 
presence of bromine. Diazotation of compound 2-amino 1, 3, 4 oxadiazole in 
hydrochloric acid in the presence of copper powder results 2 chloro 5(2, 4-
dichlorothiazol-5-yl) 1, 3, 4 oxadiazole in which aminogroup was substituted to 
chloro. In this they have done only characterization and elemental analysis. 
 
¾ Fuloria et al. (2009)14 synthesized new 1-(2-aryl-5-phenethyl-1, 3, 4 oxadiazol-
3(24)-yl) ethanones by cyclization of imines using acetic anhydride. The products 
were evaluated for antibacterial and antifungal activity. Among the newly 
synthesized compounds, 1-(2-(4-(dimethyl amino)phenyl)-5-phenethyl-1,3,4-
oxadiazol-3(2H)-yl)ethanone and 1-(2-(4-chloro phenyl)-5-phenethyl-1,3,4 
oxadiazol-3(2H)-yl)ethanone were found to possess maximum activity against the 
tested strains of S. aureus and P. aeruginosa 
 
¾ Husain et al. (2009)15 synthesized 1,3,4 oxadiazoles with erroyl propionic acid by 
condensation reaction and evaluated anti inflammatory, analgesic and antibacterial 
activity. 
 
¾ Desai NC et al. (2008)16 synthesized thiosemicarbacides, 1,2,4 triazoles, 1,3,4-
oxadiazoles derivatives by using alkaline ethanolic solution of iodine containing 
potassium iodide, orthophosphoric acid and aqueous potassium hydroxide solution. 
These compounds have been assayed for their anti microbial activity against gram 
positive and gram negative micro organism.  
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¾ Joshi SD et al. (2008)17 synthesized new 4-pyrrol-1-yl benzoic acid hydrazide 
analogs and some derived oxadiazole, triazole and pyrrole ring system. A novel 
class of potential antibacterial and anti tubercular agent. 
 
 
¾ Padmavathi V et al. (2008)18 synthesized novel sulfone- linked bis heterocycles. 
The compounds on condensation with 2-carboxy hydrazide and different aromatic 
aldehydes afford the corresponding compound and screened for antimicrobial 
activity. 
 
 
¾ Marisithambaram Karthikeyan et al. (2008)19 synthesized 2,4-dichloro-5-fluro 
phenyl containing oxadiazoles have been synthesized by mannich reaction of 5-(5-
methylisoxazol-3-yl)-1,3,4-oxadiazol-2thiol with amines and cyclization of 
hydrazones with acetic anhydride. The compounds synthesize have been confirmed 
by their elemental analysis and spectral data. The antimicrobial activities have also 
been evaluated. 
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¾ Shakya et al. (2008)20 Synthesis and biological evaluation of Schiff base of 2-
Amino-5-(2-Chlorophenyl)-1,3,4-oxadiazole using aromatic aldehydes. The 
chemical structure of these compounds was confirmed by elemental analysis, IR, 13C 
NMR. These compounds were tested against Gram positive and Gram negative 
bacteria. 
 
¾ Ajay K. Behera et al. (2006)22 synthesized bis (thiadiazolyl/ oxadiazolyl/ triazolyl) 
alkanes from dicarboxylic acid and screened for anti fungal activity 
 
 
¾ Ravindra et al. (2006)23 reported the condensation of naphtha (2, 1-b) furan-2-
carboxyhydroxide with different aromatic aldehydes affords the corresponding N-
[(IE)-aryl methylene]-naphtho[2,1-b] furan 2-carboxyhydroxide. These undergo 
cyclization with acetic anhydride and mercuric oxide to yield  3-acetyl-5-naphtho[2-
2-b] furan-2-yl-2-aryl-2,3 dihydro-1,3,4 oxadiazoles and 2 naphtho[2-1-b] furan 2-
yl-5-aryl 1,3,4-oxadiazoles on refluxing with carbon disulphide and ethanolic 
potassium hydroxide followed by acidification. These have shown antimicrobial, 
anti inflammatory activity.  
 
¾ Naga et al. (2006)24 synthesized 2,5 disubstituted 1,3,4 oxadiazole by condensation 
of 4-methoxy benzohydrazide with different aromatic acids in presence of 
phosphoryl chloride. The structural assignment of this compound has been made on  
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the basis of elemental analysis,UV,IR,1HNMR  and different strains of bacteria and 
fungi which was compared with that of standard antibiotics such as chloramphenicol 
and griseofulvin(50µg/ml) 
 
¾ Khan MSY et al. (2006)25 synthesized some new 1, 3, 4-oxadiazole derivativeswith 
different aromatic acids and aromatic aldehydes by cyclization –oxidation reaction 
of acyl hydrazones . All the products have been evaluated for their  anticonvulsant 
and antibacterial activity. 
 
 
¾ Mohan TP et al. (2004)26 Condensation of (2-oxo-3phenyl-2H-(1,8)naphthyridin-1-
yl)-acetic acid hydrazide with different acetophenones yields the corresponding 
acetophenone (2-oxo-3-phenyl-2H-(1,8)naphthyridin-1-yl)metyl carboxy 
hydrazones which on treatment with acetic anhydride affords the respective 
1,3,4oxadiazole derivative which have been confirmed on the basis of analytical and 
spectral data . 
 
¾ Holla et al. (2004)27 synthesized number of 1,3,4-oxadiazoles 2-chloropyridine is 
prepared starting from easily available 2-chloro-5-chloromethylpyridine via 2-chloro 
pyridine-5-acetic acid hydrazide.On reacting with aroyl chloride in the presence of 
pocl3 yeids 2-chloro-5-(5aryl 1,3,4oxadiazol-2-yl)methyl pyridineby esterification 
process and evaluated insecticidal activity.  
 
¾ Khan et al. (2004)28 synthesized 1,3,4-oxadiazole and isoniazid moieties are 
important because of their versatile biological actions .In present studies the 
oxadiazole has been build with isoniazid moeity and a few compound in this series 
have been synthesized evaluated their anti inflammatory and biological properties.  
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¾ Bhat et al. (2004)29 synthesized a number of 1,3,4 oxadiazole derivatives in which 
2,4 dichloro -5- fluoro benzoyl hydrazine on reacting with aromatic acids in 
presence of phosphorus oxychloride affords 2,5 disubstituted 1,3,4 oxadiazoles and 
evaluated  potential antibacterial and anticancer agents. 
 
¾ Aydogan et al. (2002)30 reported on synthesis and electronic structure of new aryl 
and alkyl-substituted 1,3,4-oxadiazole-2-thione derivatives by the ring closure 
reaction of various acyl hydrazides with carbon disulphide. Mannich bases for some 
of these compounds were also synthesized by condensation with benzaldehyde and 
primary amines. All new compounds were characterized by spectral data. Most of 
them were tested for their anti bacterial and anti tubercular activity. 
 
¾ Hui et al.(2002)31 reported 5-(5-methylisoxazol-3-yl)-4-substituted aminomethyl -2-
thio-1,3,4-oxadiazoles and 4 acetyl-2-(5-methylisoxazol 3-yl)-5-substituted-1,3,4-
oxadiazole have been synthesized by mannich reaction of 5-(5-methyl isoxazol-3-yl) 
1,3,4-oxadiazol-2-thiol with amine and cyclization of hydrazones with acetic 
anhydride respectively and evaluated antibacterial activities. 
 
¾ Sreenivasulu N et al. (2001)32 2-(Benzimidazol-2-yl)benzoyl hydrazide when 
condensed with aromatic acids in the presence of pocl3 afforded 2-aryl-5-(2-
benzimidazol-2-yl)phenyl-1,3,4-oxadiazoles. The acid hydrazide on cyclisation with 
cynogenbromide yield 2-amino-5-(2-(benzimidazol-2-yl-phenyl)-1,3,4oxadiazole 
.All the products have been evaluated for anti inflammatory and antimicrobial 
activity. 
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¾ Mogilaiah k et al. (2001)33 synthesized pyrazole and 1,3,4 oxadiazole derivatives of 
2-phenyl-1,8-naphthyridine with different aromatic aldehydes affords the 
corresponding N1-(1E)-aryl methylene)–naphtho (2,1-b) pyridine 2- carboxy 
hydrazide. These compounds undergo cyclization with acetic anhydride and 
mercuric oxide to yield 3-acetyl-5-naphthol(2,1-b)pyridine-2-yl-2aryl-2,3dihydro-
1,3,4oxadiazole and refluxing with carbondisulphide and ethanolic potassium 
hydroxide. Followed by acidification with hydrochloric acid furnishes the above 
compound. 
 
 
¾ Kagthara et al. (1999)34 reported 2-(Benzimidazol-2-yl) benzoyl hydrazide when 
condensed with aromatic acids in the presence of POCl3 afforded 2-aryl-5-[2-
benzimidazol-2-yl) phenyl]-1,3,4 oxadiazoles. The acid hydrazide on cyclisation 
with CNBr yield 2 amino-5-[2-(benzimidazol-2-yl phenyl)-1,3,4-oxadiazole which 
on reaction with aryl sulphonyl chlorides and substituted benzoyl chloride give the 
corresponding sulphonamides and amide respectively. All the products have been 
evaluated in vitro for their antimicrobial activity against several microbes and anti 
tubercular agent against mycobacterium tuberculosis. 
 
¾ Mohd.Amir et al. (1998)35 synthesized naphthyl methyl oxadiazoles, thiadiazole 
and triazole was obtained from the reaction of 2,4-dichloro thiazole-5-
carboxaldehyde and semicarbazide . 2-Amino-1,3,4-oxadiazole compound was 
synthesized via the cyclisation of compound in presence of bromine .Diazotization 
of compound in hydrochloric acid in presence of copper powder results the 
compound. 
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¾ Mohd Amir et al. (1998)36 synthesized 5-(8-quinolinoxymethyl)1,3,4 
oxadiazole/1,3,4-thiadiazole and 1,2,4 (H) triazole screened for anti inflammatory 
activity. 
 
 
¾ Shah et al (1997)37 synthesized 2-aryl amino-5-p-(nicotinamido phenyl)-1,3,4-
oxadiazoles starting from ethylnicotinamido benzoate which in turn obtained 
treatment of nicotinic acid with thionyl chloride by reacting with ethyl-para 
aminobenzoate in iodine. It has evaluated anti microbial agents. 
 
¾ Reddy VM et al. (1996)38 synthesized 2-[(3,4-Dihydro-3-oxo-2H-1,4-Benzoxazin -
2-yl)methyl]-5-(alkyl/arylthio)-1,3,4 oxadiazoles and screened for antimicrobial 
activity. 
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¾ Ladva et al. (1996)39 reported the synthesis and biological activities (anticonvulsant, 
anti-inflammatory and antimicrobial) of a number of 2,5-disubstituted 1,3,4-
oxadiazoles are described. 2-(4-isobutyl phenyl) propionic acid hydrazide is 
condensed with aromatic acids to yield 2-aryl-5-(2-methyl-4-isobutyl benzyl)-1,3,4 
oxadiazoles. 
 
¾ Kataky et al. (1990)40 reported the reaction of 2,4-di-chlorobenzoyl hydrazine and 
ethyl chloro formate and subsequent cyclisation in the presence of phosphorous oxy 
chloride will give 2-(2,4-di chlorophenyl)-1,3,4 oxadiazol-5-one(1) 4-N-Acyl aroyl-
2-(2,4-dichlorophenyl)-1,3,4-oxadiazol-5-ones were prepared by the action of 
various aliphatic and aromatic acid chlorides on (1). The fungi toxic activity was 
reported. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 12 
  
 
 
 
CHAPTER-III 
 
RESEARCH 
ENVISAGED 
 
 
 
 Chapter-III   Research Envisaged 
 
3.1 OBJECTIVE OF WORK 
In modern era, the field of pharmaceutical chemistry is changing .Now most of the 
scientists of chemistry field are trying to prepare new synthetic analogs by simple or more 
involved modifications of the structures of the natural drugs, or by pure synthesis. By 
changes in structures of the natural drugs and following the leads, there have been got, for 
instance, many new agents with higher activity and concentrate more on molecular 
modeling and computer assisted drug design. The aim of the project work is to synthesize 
new heterocyclic derivatives with potential biological activity and less adverse effects. 
 
As from the literature oxadiazole derivatives are reported to have following varieties 
of activities:- 
Antifungal13 
Antibacterial16, 27, 31 
Insecticidal24, 25 
Anti inflammatory 26,30,33,34 
Analgesic14 
Herbicidal28 
Anti malarial33 
Anti convulsant23 
Anthelmintic Activity12 
Anti tumoral27 
Anti viral32 
Anti microbial36, 39 
Muscle Relaxant27 
Tranquilizer27 
Anti tubercular Activity32 
 
Therefore based on the previously reported information concerning oxadiazole with 
different aldehyde it was planned to synthesize novel 1,3,4 oxadiazole with more biological 
and chemotherapeutic efficacy as compared to some previously reported 1,3,4 oxadiazole 
derivatives and with good yield. 
So an attempt was made to synthesize these derivatives and to screen anti-
inflammatory and anthelmintic activities. 
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Table I - List of Aldehydes used in the Synthesis 
S.NO R COMPOUND NAME 
1 
HO
O
O  
Vanillin 
2 
O
O
O  
Veratraldehyde 
3 
O
N+
O
-O
 
p-nitrobenzaldehyde 
4 
HO
O  
Salicaldehyde 
5 
O
 
4-methylbenzaldehyde 
6 
O
 
Cinnamaldehyde 
7 
O
 
Benzaldehyde 
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3.2 SCHEME 
SCHEME-I 
STEP-I 
 
HO
O
O
Vanillin
+
H2N
N
H
O
NH2H
Cl
Semicarbazide Hydrochloride
CH3COONa
heat for 3hrs
HO
O
CH N N CO NH2
 
STEP-II 
Na2CO3, Water
I2, KI
O
O
N
N
NH2
HO
4-(5-amino-1,3,4-oxadiazol-2-yl)-2 methoxy phenol  
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SCHEME-II 
STEP-I 
O
O
O
veratraldehyde
+
H2N
N
H
O
NH2H
Cl
Semicarbazide Hydrochloride
CH3COONa Heat 3 hrs
O
O
H2N
N
H
O
N
 
STEP-II 
Na2CO3, H2O
I2,KI
O
N
N
H2N
O
O
5-(3,4-dimethoxy phenyl)-1,3,4-oxadiazol-2-amine  
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SCHEME-III 
STEP-I 
+ H2N
N
H
O
NH2H
Cl
Semicarbazide Hydrochloride
CH3COONa Heat 3 hrs
OHC
4-methylbenzaldehyde
H2N
N
H
O
N
 
STEP-II 
Na2CO3, H2O
I2,KI
O
N
N
NH2
5-p-tolyl-1,3,4-oxadiazol-2-amine  
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SCHEME-IV 
 
STEP-I 
+ H2N
N
H
O
NH2H
Cl
Semicarbazide Hydrochloride
CH3COONa Heat 3 hrs
H2N
N
H
O
N
HO
O
salicaldehyde
HO
 
STEP-II 
O
N
N
NH2
OH
2-(5-amino-1,3,4-oxadiazol-2-yl)phenol
Na2CO3, H2O
I2, KI
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SCHEME-V 
STEP-I 
+ H2N
N
H
O
NH2H
Cl
Semicarbazide Hydrochloride
CH3COONa Heat 3 hrs
O
N+
O
-O
p-nitrobenzaldehyde
N+
O
-O
N
N
H
O
NH2
 
STEP-II 
Na2CO3, H2O
I2, KI
O
N
N
NH2
N+
O
-O
5-(4-nitro phenyl)-1,3,4-oxadiazol-2-amine  
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SCHEME-VI 
STEP-I 
+ H2N
N
H
O
NH2H
Cl
Semicarbazide Hydrochloride
CH3COONa Heat 3 hrs
O
Cinnamaldehyde
N
H
N
O
H2N
 
STEP-II 
Na2CO3, H2O
I2, KI
O
N N
H2N
5-Benzyl-1,3,4-oxadiazol-2amine  
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SCHEME-VII 
STEP-I 
+ H2N
N
H
O
NH2H
Cl
Semicarbazide Hydrochloride
CH3COONa Heat 3 hrs
O
Benzaldehyde
N
H
N
O
H2N
 
STEP-II 
Na2CO3, H2O
I2, KI
O
N
N
NH2
5-phenyl-1,3,4-oxadiazol-2amine  
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4. PLAN OF WORK 
 
The proposed work was planned as follows: 
1. Synthesis 
¾ Synthesis of 1,3,4 oxadiazole derivatives 
 
2. Study of physiochemical properties of the synthesized compounds 
¾ Melting point, TLC and solubility profile of the synthesized compounds. 
 
3. Characterization 
¾ Characterization of the synthesized compounds by spectral studies (IR, HNMR and 
mass spectroscopy) 
 
4. Screening of Invitro Anti inflammatory and Anthelmintic Activities 
(a) Screening of In-vitro Anti inflammatory Activity  
By HRBC Membrane Stabilization method. 
 
(b) Screening of  In-vitro Anthelmintic Activity 
Anthelmintic activity of all synthesized compounds against perionyx excavatus 
and perionyx sansibaricus (earth worm) were evaluated. 
 
 
 
 
 
 
 
 
 
 
 
 
22 
  
 
 
CHAPTER-V 
 
MATERIALS 
&  
METHODS 
 
 
 Chapter-V   Materials and Methods 
 
5. MATERIALS AND METHODS 
5.1  EXPERIMENTAL 
5.1.1 SYNTHETIC METHOD  
5.1.1.1 CHEMICALS AND INSTRUMENTS 
 
Table II - Chemical List 
S.NO CHEMICALS USED NAME OF THE MANUFACTURERS 
1.  Aldehyde Derivatives  
a) Vanillin Chemlabs 
b) Veratraldehyde Hi-Media chemicals 
c) p-nitro benzaldehyde Chemlabs 
d) Salisaldehyde Chemlabs 
e) Cinnamaldehyde Chemlabs 
f) Benzaldehyde Chemlabs 
g) 4-methyl benzaldehyde Chemlabs 
2.  Semicarbazide Hydrochloride Hi-Media chemicals 
3.  Sodium Acetate Chemlabs 
4.  Iodine Hi-Media chemicals 
5.  Potassium Iodide Hi-Media chemicals 
6.  Ethanol Hayman Limited, England 
7.  Methanol Hayman Limited, England 
8.  Chloroform Chemlabs 
9.  Tetrahydrofuran Hayman Limited, England 
10.  Dimethyl Sulfoxide Hi-Media chemicals 
 
Instruments 
1. IR Spectroscopy – Shimadzu FT 8300 
2. NMR Spectroscopy – JEOL GSX 400 
3. Mass Spectroscopy – JEOL GCmate Spectrometer 
4. UV Spectrophotometer – Shimadzu 1200 
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5.1.1.2 SYNTHESIS OF COMPOUNDS 
(a) Preparation of 1,3,4 Oxadiazole Derivatives 
Step-I: 
Chemicals Used 
Aldehyde - 0.03mole 
Semicarbazide - 0.05mole 
Ethanol - 20ml 
 
Procedure 
 A mixture of aldehyde (0.03mole) and semicarbazide HCl (0.05mole) in ethanol 
(20ml) was refluxed for 3 hours at 1000C. Solvent was distilled off and the solid mass thus 
obtained was used for further reaction. 
 
R-CHO    +    H2N-NH-CO-NH2.HCl
CH3COONa
3 hrs
R-CH=N-N-CO-NH
Aldehyde Semicarbazide Hydrochloride Intermediate  
 
Step-II: 
Chemicals Used 
Solid Mass  - 0.01mole 
Sodium Carbonate - 0.01mole 
Iodine   - 0.01mole 
Potassium Iodide - 0.01mole 
Water   - 25ml 
 
Procedure 
 The mixture of above solid mass (0.01mole) and sodium carbonate (0.01mole) was 
dissolved in water (25ml). Iodine (0.01mole) and potassium iodide (0.01mole) was refluxed 
for 2 hours at 1000C. The reaction mixture was then concentrated, allowed to cool, the solid 
product obtained was filtered, washed with water and re-crystallized using methanol. 
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R-CH=N-N-CO-NH
Na2CO3,H2O
I2,KI
NN
OR
NH2
Derivatives of 1,3,4-oxadiazole   
The percentage yield, melting point, solubility and TLC profile were studied for all 
the seven synthesized compounds. 
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5.1.2 PHARMACOLOGICAL SCREENING 
5.1.2.1 ANTI INFLAMMATORY5 
 These are the agents used to suppress the inflammation and pain sensation .The 
drugs used as anti-inflammatory and analgesic comes under the class of non steroidal anti-
inflammatory drugs and antipyretic and analgesic. All drugs grouped in this class have 
analgesic, antipyretic and anti-inflammatory action in different measures. 
 
Inflammation  
 Inflammation is defined as a defensive tissue reaction to infection, irritation or 
foreign substances. It is a part of the host defence mechanism but when it becomes great it 
is hopeless condition. There are several tissue factors or mechanism that are known to be 
involved in the inflammatory reaction such as release of histamine, bradykinins and 
prostaglandins. Inflammation is the local response of living mammalian tissue to injury due 
to any agents. It is a body defence reaction in order to eliminate or limit the spread of 
injurious agent as well as to remove the consequent necrosed cells and tissues3. 
 
Agents Causing Inflammation  
¾ Chemical agents like organic and inorganic poisons 
¾ Physical agents like heat, cold, irradiation, mechanical trauma 
¾ Infective agents like bacteria, viruses and their toxins 
¾ Immunological agents like cell-mediated and antigen-antibody reactions. 
 
Signs of Inflammation 
¾ Rubor (redness) 
¾ Tumor (swelling) 
¾ Color (heat) 
¾ Dolor (pain) 
 
Types of Inflammation 
 Depending upon the defence capacity of the host and duration of response, 
inflammation can be classified as acute and chronic. 
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 Acute Inflammation is short duration and represents the early body reaction and is 
usually followed by repair. 
  
 Chronic Inflammation is of longer duration and occurs either after the causative 
agent of acute inflammation persists for longer time or stimulus that it includes chronic 
inflammation from the beginning. 
 
Mechanism of Action6 
 The main action of NSAIDS is the inhibition of arachidonic acid-metabolizing 
activity of COX, as described originally by vanein 1971. The cyclo oxygenase enzymes are 
bifunctional, having two distinct activities; the main action which gives PGG2 and a 
peroxidase action, which converts PGG2 to GH2 .Both COX-1 and COX-2 inhibits only the 
cyclo oxygenation reaction. Both COX-1 and COX-2 are associated with the membrane and 
each consists of a long channel with a bend at the end, the channel being wider in COX-2. 
The opening of the channel is largely hydrophobic the arachidonic acid enters, is twisted 
round the bend and has two oxygen inserted in the 5-carbon ring characteristic of 
prostaglandins. 
 
 
Fig.1 - Mechanism of Action 
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 COX-1 inhibition, in general, is instantaneous and competitively reversible. COX-2 
inhibition is time dependent, i.e., its effect increases with time. Other actions of inhibition of 
COX may contribute to the anti inflammatory effect of the same NSAIDS. Reaction oxygen 
radicals produced by neutrophils and macrophages are implicated in tissue damage in some 
condition and NSAIDS that particularly strong oxygen radical scavenging effects as well as 
COX-inhibiting activity (sulindac) may decrease tissue damage. Aspirin has been shown to 
inhibit expression of the transcription factor NF-KB, which has a key role in the transaction 
of the genes for inflammatory mediators. 
 
 So from this the literature reveals that 1,3,4-oxadiazole derivatives possess anti 
inflammatory activity. So an attempt was made to screen the synthesized compounds for 
anti inflammatory activity. 
 
5.1.2.2  IN VITRO ANTI INFLAMMATORY ACTIVITY10 
Method 
 The Human Red Blood Cells (HRBC) membrane stabilization has been used as a 
method to study the anti-inflammatory activity. 
 
Chemicals and Reagents Used 
• Diclofenac Sodium 
• Hypo saline (0.36%) 
• Isosaline (0.85%, pH 7.2) 
• Phosphate Buffer (0.15M, pH 7.2) 
• Alsever Solution 
 
Preparation of Alsever Solution 
 Alsever solution was prepared by 2% dextrose, 0.8% sodium citrate, 0.05% citric 
acid and 0.42% sodium chloride dissolved in distilled water and sterilized. 
 
Procedure 
 Blood was collected from healthy volunteers. The collected blood was mixed with 
equal volume of sterilized alsever solution.  
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The blood was centrifuged at 3000 rpm and packed cells were washed with isosaline 
and a 10% (v/v) suspension was made with isosaline. 
 
 Two solutions of each synthesized compounds were prepared (each 
containing100µg/ml) and to each solution added 1 ml phosphate buffer, 2ml of hyposaline 
and 0.5ml HRBC suspension diclofence sodium was used as a reference drug. Instead of 
hypo saline, 2ml of distilled was used as control. The array mixtures were incubated at 370C 
for 30 min and centrifuged. The hemoglobin content in supernatant solution was estimated 
using UV analysis at 560nm. The % hemoglobin was calculated by assuming the 
hemoglobin produced in the presence of distilled water as 100%. The percentage of HRBC 
membrane stabilization or protection was calculated using the formula 
       O.D of Test-O.D of Product 
% prevention of Hemoglobin = 100 X    ------------------------------------------- 
                       O.D of Control  
 The control represents 100% lysis. The result was compared with standard 
diclofenac (50µg/ml). 
 
5.1.2.2 INVITRO ANTHELMINTIC ACTIVITY11 
Anthelmintics or antihelminthics are drugs that expel parasitic worms (helminths) 
from the body, by either stunning or killing them. They may also be called vermifuges 
(stunning) or vermicides (killing). 
 
Anthelmintic Resistance 
The ability of worms to survive treatments that are generally effective at the 
recommended dose rate is considered a major threat to the future control of worm parasites 
of small ruminants and horses. 
 
Treatment with an antihelminthic drug kills worms whose genotype renders them 
susceptible to the drug. Worms that are resistant survive and pass on their "resistance" 
genes. Resistant worms accumulate and finally treatment failure occurs. 
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Types of Worm Species Found In India 
• Perionyx excavatus 
• Perionyx sansibaricus 
• Eisenia foetida 
• Eisenia eugeniae 
• Lampito mauritti 
• Pontoscolex corethrurus 
• Pheretima posthuma 
• Octochaetona serrata 
 
Materials Collected 
Two different species of earth worms (perionyx excavatus and perionyx 
sansibaricus-obtained from Bell foundation, Thiruvanmiyur, Chennai-41) of nearly equal 
size were selected for present study. 
 
Perionyx excavatus, Perionyx sansibaricus are commercially produced earthworms. 
They are also known as "blues" or "Indian blues". They belong to the Perionyx genus. Their 
origins may be the Himalayan Mountains. This species is particularly good for 
vermicomposting in tropical and subtropical regions. 
 
Earth worms are washed with normal saline to remove all the faecal matter. The 
earth worms of 3-5cm in length and 0.1-0.2cm width were selected for the experimental 
protocol. 
 
Procedure    
 Anthelmintic activity12 was carried out against P.excavatus, P.sansibaricus species 
at 2 mg/ml concentration. Suspension of samples was prepared by triturating synthesized 
compounds (100mg) with tween 80(0.5%) and distilled water and the resulting mixtures 
were stirred using a mechanical stirrer for 30 min. The suspensions were diluted to contain 
0.2% w/v of the test samples. Suspension of reference drug and piperazine citrate was 
prepared with the same concentration in a similar way. Two sets of five earthworms of 
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almost similar sizes (2 inch in length) were placed in Petri plates of 4 inch diameter 
containing 10 ml suspension of test sample and reference drug. Another set of five 
earthworms was kept as control in 10 ml suspension of distilled water and Tween 80(0.5%). 
The paralyzing and death times were noted and their means were calculated. The death time 
was ascertained by placing the earthworms in warm water (50oC) which stimulated the 
movement, if the worm was alive. The results are presented in Table XI. 
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6. RESULTS AND DISCUSSION 
 At present in the scheme, the 1, 3, 4 oxadiazole derivatives were synthesized by 
using different aldehyde with yields between 70-83%. The molecular structure and IUPAC 
name for all seven synthesized compounds are tabulated in Table-III. 
 
The solubility and TLC profile were studied for all the seven synthesized 
compounds and the results are tabulated in Table IV and V. 
 
The melting points of all synthesized compounds were found in open capillary tubes 
and readings were uncorrected. The elemental analysis was determined and the results are 
tabulated in table VI. The found values of the elements by elemental analysis were closer to 
calculated values. 
 
The IR spectra of the compounds were done in a shimadzu FT 8300 infrared 
spectrophotometer (Vmax cm-1) by using KBr discs. The results of IR spectra are given in 
the table VII and it shows that the functional groups such as phenolic hydroxyl, carbonyl, 
amino, nitro phenyl and methoxy groups may be present in the synthesized compounds. 
 
The mass spectra of all the synthesized compounds were done on a JEOL GC mate 
spectrometer. The results presented in the table VIII shows that the molecular mass of the 
synthesized compounds was nearer to the molecular mass of the expected compounds. 
 
The 1HNMR spectra of the synthesized 1, 3, 4 oxadiazole derivative were recorded 
on JEOL GSX400 spectrometer using TMS as internal standard (chemical shifts in δ, PPm) 
and DMSO as the solvent. The results of 1HNMR spectra given in table IX shows that the 
numbers of hydrogen atoms present in all the synthesized compounds were exact when 
compared to the number of hydrogen atoms in the expected compounds. 
 
The synthesized compounds were screened for their invitro anti-inflammatory 
activity by membrane stabilization method. The results are given in table XI. All the 
synthesized compounds showed good anti-inflammatory activity. Out of all the synthesized 
compounds 1A, 1B, 1E showed significant anti-inflammatory activity when compared with  
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that of standard where as the compound 1C, 1D, 1F, 1G showed less when compared to that 
of standard diclofenac. 
 
The literature shows that the compounds having methoxy,nitro,hydroxyl groups 
possess significant anti inflammatory activity22when compared to other groups .The 
synthesized compound 1A,1B,1E possess OCH3,OH,nitro group in its structure. So the anti 
inflammatory activity may be due to the presence of the respective functional groups as 
evidence in literature. 
 
The anthelmintic activity was carried out using two species of earth worms. The 
synthesized compounds showed good anthelmintic property the activity may be due to 
presence of methyl and nitro group in the compound which has been proved in the earlier 
report12. 
 
The paralyzing and death times were noted and their means are calculated which 
were tabulated in Table XI. 
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Table III - List of Compounds Synthesized 1A-1G 
 
COMPOUNDS STRUCTURE IUPAC NAME 
 
1A 
O
O
N
N
NH2
HO
 
4-(5-amino-
1,3,4-oxadiazol-
2-yl)-2 methoxy 
phenol 
 
1B 
O
N
N
H2N
O
O
 
5-(3,4-
dimethoxy 
phenyl) -1,3,4-
oxadiazol-2-
amine 
 
1C 
O
N
N
NH2
 
5-p-tolyl-1,3,4-
oxadiazol-2-
amine 
 
1D 
O
N
N
NH2
OH
 
2-(5-amino-
1,3,4-oxadiazol-
2-yl)phenol 
 
1E 
O
N
N
NH2
N+
O
-O
 
5-(4-
nitrophenyl)-
1,3,4-oxadiazol-
2-amine 
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1F 
O
N N
NH2
 
5-Benzyl-1,3,4-
oxadiazol-2amine 
1G 
O
N N
H2N
 
5-phenyl-1,3,4-
oxadiazol-2amine 
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 TABLE IV - Solubility data of the synthesized compound 1A-1G 
COMPOUNDS WATER ACETONE CHLOROFORM DMSO ETHANOL METHONAL ETHYL ACETATE 
GLACIAL 
ACETIC ACID DMF 
1A - - ++ ++ + ++ - - + 
1B - - + ++ + + - - + 
1C - - ++ ++ + + - - + 
1D - - ++ ++ + + - - + 
1E - - ++ ++ + + - - + 
1F - - + ++ + + - - + 
1G - - + ++ + + - - + 
 
++  = Freely Soluble  
+ = Slightly Soluble 
- = Insoluble 
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Table V - TLC Profile of the Synthesized Compounds 
 
 
 
Adsorbent Used : Pre coated Silica gel G  
Mobile Phase     : Chloroform and Methanol 
Detection Techniques : UV Chamber 
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SOLVENT RATIO 
S.NO COMPOUND  
CHLOROFORM METHANOL 
Rf VALUE 
1 1A 50 50 0.70 
2 1B 70 30 0.73 
3 1C 60 40 0.71 
4 1D 70 30 0.75 
5 1E 50 50 0.68 
6 1F 50 50 0.76 
7 1G 70 30 0.78 
  
 
Table VI - Elemental Analysis Data of Compounds 1A-1F 
Elemental Analysis of Compounds (%) Found S.No Compound Mol. Formula m.p0C Molecular Weight Yield in Percentage 
C H N O 
1 1A C9H9N3O3 119 207.19 76 52.17 4.38 20.28 23.17 
2 1B C10H11N3O3 132 221.21 83 54.29 5.01 19.00 21.70 
3 1C C9H9N3O 140 175.19 70 61.70 5.18 23.99 9.13 
4 1D C8H7N3O2 147 177.16 75 54.24 3.98 23.72 18.06 
5 1E C8H6N4O3 136 206.16 80 46.61 2.93 27.18 23.28 
6 1F C9H9N3O 145 175.19 82 61.70 5.18 23.99 9.13 
7 1G C8H7N30 150 161.16 76 59.62 4.38 26.07 9.93 
 
  
 
Table VII - IR Spectral data of the synthesized compounds 1A-1G 
 
Compounds C-H(Ar) (cm-1) 
C=O 
(cm-1) 
C-H (s) 
(cm-1) 
C=C 
(cm-1) 
C-N 
(cm-1) 
C=N 
(cm-1) 
C-H (b) 
(cm-1) 
C-O-
CH3 
(cm-1) 
Phenolic 
OH (s) 
(cm-1) 
Phenolic 
OH (b) 
(cm-1) 
C-NO2 
(cm-1) 
C-NH2 
(cm-1) 
C-Cl 
(cm-1) 
1A 2771 - - 1536 1434 1680 1140 - 3864 1230 - 3915 - 
1B 3250 - - 1502 1486 1692 1114 - - - - 3930 - 
1C 2794 - - 1370 1299 1658 1154 - - - - 3750 - 
1D 2696 - - 1400 1269 1621 1158 - 3843 1215 - 3343 - 
1E 2869 - - 1452 1405 1673 1211 - - - 1464 3841 - 
1F 3185 - - 1299 1269 1692 1164 - - - - 3217 - 
1G 3644 - - 1277 1230 1683 1121 - - - - 3372 - 
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Table VIII – MASS Spectral data of the Synthesized Compounds 1A-1G 
 
S.No Compounds Molecular 
Weight 
M/Z (% Relative Abudance) 
1 1A 207.19 
209.53M+(35%), 202.57B(155%), 166.45(55%), 149.44(100%), 134.40(55%), 
124.43(30%), 117.42(15%), 106.38(30%), 93.39(20%), 69.36(17%), 58.38(35%) 
2 1B 221.21 221.12 M+(45%), 149.4B(100%), 134.40(50%), 106.38(36%), 93.39(29%), 58.34(38%) 
3 1C 175.19 
175.19M+(50%), 119.42B(100%), 61.32(100%), 91.38(75%), 107.43(45%), 77.37(55%), 
69.38 (19%), 73.36(18%), 83.40(17%), 102.38(20%), 122.42(81%) 
4 1D 177.16 
177.49 M+( (42%), 133.43B(100%), 117.42(99%), 61.33(98%), 91.38(55%), 
106.41(50%), 77.35(38%), 65.34(22%), 69.37(10%) 
5 1E 206.16 
206.16 M+( (25%), 166.45B(50%), 149.44(100%), 134.40(55%), 124.43(30%), 
106.38(32%), 93.39(20%), 83.40(10%), 69.36(15%), 65.34(35%) 
6 1F 175.19 
177.49 M+( (40%), 133.43B(100%), 117.42(99%), 61.33(98%), 91.38(55%), 
106.41(50%), 77.35(38%), 65.34(26%), 69.37(7%), 103.411(15%) 
7 1G 161.16 
162.47 M+( (20%), 135.42B(50%), 119.42(100%), 91.38(75%), 77.37(50%), 
58.34(55%), 69.38(10%), 73.36(7%), 122.42(12%), 129.48(5%) 
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Table IX - 1HNMR Spectral Data of the Synthesized Compounds 1A-1F 
 
Compounds Nature of Proton 
Aromatic 
Proton 
(Ar-H) 
(m) 
N=CH-Ar 
(s) 
-CH3 
(s) 
C-O-CH3 
(s) 
Ar-OH 
(s) 
N(CH3)2 
(s) -OCH3 (s) -NH2(s) 
Total 
No. of 
Proton 
1A 
No. of 
Proton δ 
value (ppm) 
 
3H 
3.73-6.87 
 
- 
 
- 
 
- 
 
1H 
5.0 
 
- 
 
3H 
3.73 
 
2H 
4.0 
 
9 
1B 
No. of 
Proton δ 
value (ppm) 
 
3H 
3.83-6.93 
 
- 
 
- 
 
- 
 
- 
 
- 
 
6H 
3.73 
 
2H 
4.0 
 
11 
1C 
No. of 
Proton δ 
value (ppm) 
 
4H 
2.35-7.36 
 
- 
 
3H 
2.35 
 
-- 
 
- 
  
 - 
 
- 
 
2H 
4.0 
 
9 
1D 
No. of 
Proton δ 
value (ppm) 
 
4H 
4.0-7.31 
 
- 
 
- 
 
- 
 
1H 
5.0 
 
- 
 
- 
 
2H 
4.0 
 
7 
1E 
No. of 
Proton δ 
value (ppm) 
 
4H 
4.0-8.25 
 
- 
 
- 
 
 
  
 - 
 
- 
 
- 
 
2H 
4.0 
 
6 
1F 
No. of 
Proton δ 
value (ppm) 
 
6H 
3.81-7.14 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
2H 
4.0 
 
8 
1G 
No. of 
Proton δ 
value (ppm) 
 
5H 
4.0-7.48 
 
- 
 
- 
  
 - 
 
- 
 
- 
 
- 
 
2H 
4.0 
 
7 
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Table X - Invitro Anti inflammatory Activity of Synthesized Compounds 1A-1G 
 
Concentration µg/ml 
Absorbance at 540nm S.No. Compounds 
25 50 100 
% Prevention 
of Lysis 
1 1A 0.15±0.001** 0.19±0.002* 0.20±0.001* 69.6 
2 1B 0.20±0.04* 0.22±0.07* 0.16±0.04** 58.1 
3 1C 0.35 ±0.03* 0.36±0.01* 0.38±0.005* 28.6 
4 1D 0.32±0.03* 0.33±0.04* 0.35±0.05* 31.0 
5 1E 0.22±0.001* 0.28±0.007* 0.27±0.08** 60.5 
6 1F 0.30±0.04* 0.35±0.04* 0.32±0.04* 30.2 
7 1G 0.20±0.04* 0.27±0.04* 0.25±0.06* 43.3 
8 Control - - - - 
9 Diclofenac  0.14±0.002*  74.8 
 
                   Values are expressed as mean ±SEM  
P*<0.01 – Moderate P**<0.001 – Significant 
One way ANOVA followed by Dunnett’s  ‘t’ test 
 
 
 
Graph-1 
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Table XI - Invitro Anthelmintic Activity of synthesized compounds 1A-1G 
 
Earthworm Species 
P.excavatus P.sansibaricus 
Compound Mean 
Paralysis Time 
(min) 
Mean Death 
Time (min) 
Mean 
Paralysis Time 
(min) 
Mean Death 
Time (min) 
1A 09.35±0.67 11.23±0.53 11.91±0.99 13.97±0.64 
1B 09.52±0.54 11.52±0.57 11.03±0.20 13.73±0.07 
1C 09.95±0.51 11.99±0.98 15.00±0.62 17.45±0.60 
1D 07.56±0.56 09.76±0.94 09.23±0.45 11.89±0.57 
1E 09.88±0.90 11.92±0.99 14.95±0.63 16.21±0.96 
1F 08.23±0.56 10.35±0.47 12.00±0.98 14.95±0.74 
1G 08.65±0.23 10.98±0.34 10.34±0.47 12.00±0.95 
Control - - - - 
Piperazine 
Citrate 13.40±0.47 14.63±0.50 20.07±0.68 33.34±0.89 
 
* Data are given as the mean ±S.D 
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7. SUMMARY AND CONCLUSION 
Molecular modification of simple and complex chemical entities may lead to 
biological active compounds. Different types of approaches are made to derive such 
compounds which exhibit selective pharmacological activity. 1, 3, 4 oxadiazole derivatives 
show potent anti-inflammatory and anthelmintic activities. 
 
This research work was oriented towards the finding of derivatives of 1, 3, 4 
oxadiazole with anti inflammatory and anthelmintic activities. The different substituted 
aldehyde derivatives were synthesized by condensation reactions. Seven compounds have 
been synthesized and all the compounds were labeled 1A-1G. 
 
Using different analytical techniques, namely, elemental analysis, IR, 1HNMR and 
Mass spectroscopical studies the structure of the different substituted 1, 3, 4 oxadiazole 
derivatives were confirmed. 
 
The newly synthesized 1, 3, 4 oxadiazole derivatives were evaluated for their invitro 
anti-inflammatory by membrane stabilization method. All the synthesized compounds sho 
wed anti inflammatory activity. Out of all the synthesized compounds 1A and 1B and 
1E showed significant anti inflammatory activity. All the other compound shows moderate 
anti inflammatory activity when compared with that of standard diclofenac. 
 
The literature shows that the compounds having methoxy, nitro, hydroxyl groups 
possess significant anti inflammatory activity33. The synthetic compounds 1A, 1B, 1E 
possess OCH3, OH, nitro group in its structure. So the anthelmintic activity may be due to the 
presence of the respective functional groups as evidence in literature. 
 
The anthelmintic activity was carried out using two species of earth worm. The 
synthesized compounds show good anthelmintic activity out of all the synthesized 
compounds. Compound 1C and 1E showed good anthelmintic property. The activity may be 
due to the presence of methyl and nitro group in the compound which has been proved in 
earlier reports12. 
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